Olanzapine pamoate in the spektrum of long-acting antipsychotics

Abstract

First generation antipsychotics were only available in long-acting depot preparations in the past, with common maintenance treatment results complicated by adverse effects. Olanzapine pamoate is another second generation antipsychotic available in long-acting injection.

The efficacy for acute and maintenance treatment of olanzapine pamoate was demonstrated in clinical trials in patiens with schizophrenia.

Keywords

• non-adherence
• antipsychotic long-acting injection
• schizophrenia
• olanzapine pamoate